| mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |
| mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-05 |
| mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |
| mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
| mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
3e-05 |
| mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
3e-05 |
| mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-05 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
| mRNA |
I-BET-762 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
5e-05 |
| mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-05 |